Search Results - "Göhlmann, Hinrich W. H"

Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis by Andries, Koen, Verhasselt, Peter, Guillemont, Jerome, Göhlmann, Hinrich W. H, Neefs, Jean-Marc, Winkler, Hans, Van Gestel, Jef, Timmerman, Philip, Zhu, Min, Lee, Ennis, Williams, Peter, de Chaffoy, Didier, Huitric, Emma, Hoffner, Sven, Cambau, Emmanuelle, Truffot-Pernot, Chantal, Lounis, Nacer, Jarlier, Vincent

“…The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been…”
Get full text

FABIA: factor analysis for bicluster acquisition by Hochreiter, Sepp, Bodenhofer, Ulrich, Heusel, Martin, Mayr, Andreas, Mitterecker, Andreas, Kasim, Adetayo, Khamiakova, Tatsiana, Van Sanden, Suzy, Lin, Dan, Talloen, Willem, Bijnens, Luc, Göhlmann, Hinrich W. H., Shkedy, Ziv, Clevert, Djork-Arné

“…Motivation: Biclustering of transcriptomic data groups genes and samples simultaneously. It is emerging as a standard tool for extracting knowledge from gene…”
Get full text

Integrating High-Dimensional Transcriptomics and Image Analysis Tools into Early Safety Screening: Proof of Concept for a New Early Drug Development Strategy by Verbist, Bie M. P, Verheyen, Geert R, Vervoort, Liesbet, Crabbe, Marjolein, Beerens, Dominiek, Bosmans, Cindy, Jaensch, Steffen, Osselaer, Steven, Talloen, Willem, Van den Wyngaert, Ilse, Van Hecke, Geert, Wuyts, Dirk, Van Goethem, Freddy, Göhlmann, Hinrich W. H

“…During drug discovery and development, the early identification of adverse effects is expected to reduce costly late-stage failures of candidate drugs. As…”
Get full text

Tales of 1,008 small molecules: phenomic profiling through live-cell imaging in a panel of reporter cell lines by Cox, Michael J., Jaensch, Steffen, Van de Waeter, Jelle, Cougnaud, Laure, Seynaeve, Daan, Benalla, Soulaiman, Koo, Seong Joo, Van Den Wyngaert, Ilse, Neefs, Jean-Marc, Malkov, Dmitry, Bittremieux, Mart, Steemans, Margino, Peeters, Pieter J., Wegner, Jörg Kurt, Ceulemans, Hugo, Gustin, Emmanuel, Chong, Yolanda T., Göhlmann, Hinrich W. H.

“…Phenomic profiles are high-dimensional sets of readouts that can comprehensively capture the biological impact of chemical and genetic perturbations in…”
Get full text

Understanding drugs in breast cancer through drug sensitivity screening by Uhr, Katharina, Prager-van der Smissen, Wendy J. C., Heine, Anouk A. J., Ozturk, Bahar, Smid, Marcel, Göhlmann, Hinrich W. H., Jager, Agnes, Foekens, John A., Martens, John W. M.

“…With substantial numbers of breast tumors showing or acquiring treatment resistance, it is of utmost importance to develop new agents for the treatment of the…”
Get full text

I/NI-calls for the exclusion of non-informative genes: a highly effective filtering tool for microarray data by Talloen, Willem, Clevert, Djork-Arné, Hochreiter, Sepp, Amaratunga, Dhammika, Bijnens, Luc, Kass, Stefan, Göhlmann, Hinrich W.H.

“…Motivation: DNA microarray technology typically generates many measurements of which only a relatively small subset is informative for the interpretation of…”
Get full text

Alterations in Mucosal Immunity Identified in the Colon of Patients With Irritable Bowel Syndrome by Aerssens, Jeroen, Camilleri, Michael, Talloen, Willem, Thielemans, Leen, Göhlmann, Hinrich W.H, Van den Wyngaert, Ilse, Thielemans, Theo, De Hoogt, Ronald, Andrews, Christopher N, Bharucha, Adil E, Carlson, Paula J, Busciglio, Irene, Burton, Duane D, Smyrk, Thomas, Urrutia, Raul, Coulie, Bernard

“…Background & Aims: Irritable bowel syndrome (IBS) has been associated with mucosal dysfunction, mild inflammation, and altered colonic bacteria. We used…”
Get full text

The high-level similarity of some disparate gene expression measures by Raghavan, Nandini, De Bondt, An M. I. M., Talloen, Willem, Moechars, Dieder, Göhlmann, Hinrich W. H., Amaratunga, Dhammika

“…Probe-level data from Affymetrix GeneChips can be summarized in many ways to produce probe-set level gene expression measures (GEMs). Disturbingly, the…”
Get full text

Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis by Ravindranath, Aakash Chavan, Perualila-Tan, Nolen, Kasim, Adetayo, Drakakis, Georgios, Liggi, Sonia, Brewerton, Suzanne C, Mason, Daniel, Bodkin, Michael J, Evans, David A, Bhagwat, Aditya, Talloen, Willem, Göhlmann, Hinrich W H, Shkedy, Ziv, Bender, Andreas

“…Integrating gene expression profiles with certain proteins can improve our understanding of the fundamental mechanisms in protein-ligand binding. This paper…”
Get more information

Genomic Biomarkers for a Binary Clinical Outcome in Early Drug Development Microarray Experiments by Van Sanden, Suzy, Shkedy, Ziv, Burzykowski, Tomasz, Göhlmann, Hinrich W. H., Talloen, Willem, Bijnens, Luc

“…In this article, we discuss methods to select three different types of genes (treatment related, response related, or both) and investigate whether they can…”
Get full text

Identification and complementation of frameshift mutations associated with loss of cytadherence in Mycoplasma pneumoniae by Fisseha, M, Göhlmann, H W, Herrmann, R, Krause, D C

“…Mycoplasma pneumoniae cytadherence is mediated by a specialized, polar attachment organelle. Certain spontaneously arising cytadherence mutants (designated…”
Get full text

Weighted similarity-based clustering of chemical structures and bioactivity data in early drug discovery by Perualila-Tan, Nolen Joy, Shkedy, Ziv, Talloen, Willem, Göhlmann, Hinrich W H, Moerbeke, Marijke Van, Kasim, Adetayo

“…The modern process of discovering candidate molecules in early drug discovery phase includes a wide range of approaches to extract vital information from the…”
Get more information

Identification of a small RNA within the pdh gene cluster of Mycoplasma pneumoniae and Mycoplasma genitalium by Göhlmann, H W, Weiner, 3rd, J, Schön, A, Herrmann, R

“…A highly abundant and heterogeneous small RNA about 205 to 210 bases long named MP200 RNA has been identified in Mycoplasma pneumoniae. It was localized on the…”
Get full text

Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism by Koul, Anil, Vranckx, Luc, Dhar, Neeraj, Göhlmann, Hinrich W.H., Özdemir, Emre, Neefs, Jean-Marc, Schulz, Melanie, Lu, Ping, Mørtz, Ejvind, McKinney, John D., Andries, Koen, Bald, Dirk

“…Bedaquiline (BDQ), an ATP synthase inhibitor, is the first drug to be approved for treatment of multidrug-resistant tuberculosis in decades. Though BDQ has…”
Get full text

Analysis of Affymetrix GeneChip data using amplified RNA by Cope, Leslie, Hartman, Scott M, Göhlmann, Hinrich W H, Tiesman, Jay P, Irizarry, Rafael A

“…When small biological samples are collected by microdissection or other methods, amplification techniques are required to provide sufficient target for…”
Get full text

Gene filtering in the analysis of Illumina microarray experiments by Forcheh, Anyiawung Chiara, Verbeke, Geert, Kasim, Adetayo, Lin, Dan, Shkedy, Ziv, Talloen, Willem, Göhlmann, Hinrich W H, Clement, Lieven

“…Illumina bead arrays are microarrays that contain a random number of technical replicates (beads) for every probe (bead type) within the same array. Typically…”
Get more information

Comparison of methods for the selection of genomic biomarkers by Lin, Dan, Tilahun, Abel, Abrahantes, Jose Cortinas, Shkedy, Ziv, Molenberghs, Geert, Gohlmann, Hinrich W H, Talloen, Willem, Bijnens, Luc

“…In recent years, a lot of attention is placed on the selection and evaluation of biomarkers in microarray experiments. Two sets of biomarkers are of…”
Get more information

Transcriptional Characterization of Compounds: Lessons Learned from the Public LINCS Data by De Wolf, Hans, De Bondt, An, Turner, Heather, Göhlmann, Hinrich W H

“…The NIH-funded LINCS program has been initiated to generate a library of integrated, network-based, cellular signatures (LINCS). A novel high-throughput…”
Get more information

A joint modeling approach for uncovering associations between gene expression, bioactivity and chemical structure in early drug discovery to guide lead selection and genomic biomarker development by Perualila-Tan, Nolen, Kasim, Adetayo, Talloen, Willem, Verbist, Bie, Göhlmann, Hinrich W H, Shkedy, Ziv

“…The modern drug discovery process involves multiple sources of high-dimensional data. This imposes the challenge of data integration. A typical example is the…”
Get more information

Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR project by Verbist, Bie, Klambauer, Günter, Vervoort, Liesbet, Talloen, Willem, Shkedy, Ziv, Thas, Olivier, Bender, Andreas, Göhlmann, Hinrich W.H., Hochreiter, Sepp

“…•Transcriptomics can de-risk drug development in early phases by identifying side-effects.•Transcriptomics successfully prioritized compounds in drug discovery…”
Get full text